Navigation Links
MediVet Biologics Launches Innovative Immunotherapy Trial for Canine Cancer
Date:7/11/2017

MediVet Biologics, a global leader in veterinary biologic solutions for pets announced today in partnership with the Veterinary Cancer Group (Los Angeles, CA) a trial for dogs stricken with cancer. The trial involves a breakthrough strategy of combining a personalized immunotherapy vaccine with specialty cancer standards of care.

K9ACV is a service provided by MediVet Biologics which allows for an affordable personalized immunotherapy vaccine for canine cancer. The immunotherapy cancer vaccine was developed by MediVet Biologics in partnership with researchers from the University of Kentucky Markey Cancer Center.

Immunotherapy is a cutting-edge strategy designed to assist the patient’s own immune system to work harder and more efficiently to attack cancer from within.

K9ACV is being studied by the veterinarian oncology team at Veterinary Cancer Group to be used in conjunction with current treatment strategies such as chemotherapy and radiation. The goal, is to study a multi modal approach to canine cancer to see if it can offer better outcomes when patients are in various stages of disease.

Greater than 50% of dogs over the age of ten will develop cancer and early detection is often difficult. The trial is now open and available to owners of canine patients with any form of cancer in the Orange County, San Fernando Valley & Los Angeles California areas.

In late 2016, an initial paper was published on the vaccine service and the company just finished an additional trial utilizing the vaccine for cancer patients at Kansas State University College of Veterinary Medicine.

Thomas Masterson, VP of Business Development, MediVet Biologics, “We have already had tremendous success utilizing K9ACV on patients who were not candidates for specialty cancer care. Our hope is that by combining our immunotherapy treatment with other established methodologies of canine oncology care we can make this service available to more patients in need and offer increased survival for the patient. We are fortunate to have partnered with a progressive group of oncologists such as the team at VCG.”    

About MediVet Biologics

MediVet Biologics is a animal health company focused on providing innovative strategies to fight diseases and redefine pet healthcare. Since 2010 the company has provided services to a network of thousands of progressive veterinarians such as Actistem™ Stem Cell Therapy and other biologic treatments designed to rebuild and repair processes naturally without dependency on drugs. Each product and service is designed to offer alternatives to improve the lives of pets and their owners.
http://www.medivetbiologics.com

Read the full story at http://www.prweb.com/releases/2017/07/prweb14494704.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. MediVet Biologics to Host Biologics Symposium at Western Veterinary Conference
2. MediVet Biologics to Present University Study on Canine Stem Cells during 2016 North American Veterinary Conference
3. MediVet Biologics Completes Initial Cancer Trial Utilizing Immunotherapy
4. MediVet Biologics Announces Appointment of Jeff Baker as New Chief Operating Officer
5. MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas
6. MediVet Biologics Acquires Exclusive Patent License from Kansas State University
7. MediVet Biologics adds Merritt Veterinary Supplies, Inc. as a Distribution Partner of Veterinary Stem Cell and other Biologic treatment options.
8. MediVet Biologics to Host Progressive Summit on Animal Health Biologic Treatment Options at 2015 AVMA Convention in Boston
9. World’s first tendon replacement using Nanofiber and activated MediVet Stem Cell Fraction
10. MediVet America Secures Exclusive Worldwide License with Nanofiber Veterinary
11. Catalent Biologics Announces Collaboration with Therachon, Switzerland, to Advance Clinical Development of Innovative Protein Therapy for Achondroplasia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2018)... ... September 29, 2018 , ... Voxx Analytics announces the ... access the power of influence analytics and data-driven engagement decision making. , “For ... that didn’t necessarily have access to the same financial resources as our Top ...
(Date:9/27/2018)... ... September 26, 2018 , ... Medable was ... aims to build the first human digitome, a digital representation of human health ... a seamless integration of all data sources. Dr. Michelle Longmire, Co-Founder and CEO ...
(Date:9/22/2018)... HAYWARD, Calif. and WESTMINSTER, Colo. (PRWEB) , ... ... ... Predicine and Flagship Biosciences are excited to announce a strategic venture. ... intelligence-enabled cTA® digital pathology platform provides complimentary and comprehensive biomarker profiling to ...
(Date:9/13/2018)... , ... September 13, 2018 , ... Asymmetrex’s ... think we would have gotten in medicine, if we didn’t have the means to ... to treat patients?” His answer, “Nowhere! And that is what’s holding up progress ...
Breaking Biology Technology:
(Date:10/11/2018)... ... October 09, 2018 , ... ... supports high-growth, high-impact life science and biotechnology companies, announced today that it ... foundations to discuss their investment philosophies, explain their fund and deal structures, ...
(Date:10/11/2018)... ... October 11, 2018 , ... The American College of Medical Informatics (ACMI) will ... PhD, Director of the National Library of Medicine (NLM), during the Opening Session of ... taking place Nov. 3 – 7. , In honor of Morris F. Collen, a ...
(Date:10/5/2018)... ... October 04, 2018 , ... ... Illinois Extension and Monroe County Economic Development Corporation (EDC), has been awarded ... Food and Agriculture (NIFA) Non-Land Grant College of Agriculture (NLGCA) Capacity-Building grants ...
Breaking Biology News(10 mins):